Roivant Sciences (ROIV) Shares Outstanding (Diluted) (2021 - 2026)
Roivant Sciences (ROIV) recorded Shares Outstanding (Diluted) of 720.78 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 6.0% from 680.29 million a year earlier and up 3.9% from the prior quarter.
Powered by 
Analysis
Roivant Sciences (ROIV) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Roivant Sciences reported Shares Outstanding (Diluted) of 693.86 million, down 4.3% from FY2025.
- Annual Shares Outstanding (Diluted) has a four-year compound annual growth rate of 0.9% (FY2022 to FY2026).
- Across earlier fiscal years, Shares Outstanding (Diluted) came in at 725.4 million in FY2025 (-12.7%), 831.05 million in FY2024 (+16.6%), 712.79 million in FY2023 (+6.4%) and 669.75 million in FY2022.
- The fiscal Q1 2027 figure is the highest quarterly Shares Outstanding (Diluted) since fiscal Q4 2025.
- On a year-over-year basis, Shares Outstanding (Diluted) rose in 1 of the last eight quarters, with an average decline of 6.7%.
- Peak year-over-year performance for Shares Outstanding (Diluted) in the last five years was growth of 18.4% in fiscal Q3 2024, against a decline of 14.4% in fiscal Q3 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at 693.86 million (Q4 2026), 696.86 million (Q3 2026) and 680.95 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Roivant Sciences | 26.43 Bn | 27.12 Bn | 1.16 Mn | 720.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 720.78 Mn |
| Mar 31, 2026 | 693.86 Mn |
| Dec 31, 2025 | 696.86 Mn |
| Sep 30, 2025 | 680.95 Mn |
| Jun 30, 2025 | 680.29 Mn |
| Mar 31, 2025 | 725.40 Mn |
| Dec 31, 2024 | 722.72 Mn |
| Sep 30, 2024 | 735.47 Mn |
| Jun 30, 2024 | 781.63 Mn |
| Mar 31, 2024 | 831.05 Mn |
| Dec 31, 2023 | 844.46 Mn |
| Sep 30, 2023 | 770.23 Mn |
| Jun 30, 2023 | 759.27 Mn |
| Mar 31, 2023 | 712.79 Mn |
| Dec 31, 2022 | 713.32 Mn |
| Sep 30, 2022 | 699.89 Mn |
| Jun 30, 2022 | 695.88 Mn |
| Mar 31, 2022 | 669.75 Mn |
| Dec 31, 2021 | 686.59 Mn |
| Sep 30, 2021 | 650.23 Mn |
API Access
Roivant Sciences Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();